Stock Rich List
Nasdaq: RNAC

Cartesian Therapeutics insiders

The officers, directors and 10% owners of Cartesian Therapeutics, Inc. who hold the most stock, valued at the live RNAC price.

$5.89
RNAC today −$410K (−6.51%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their RNAC stock
$114M
Market value
$189M
Held by ranked insiders
60.7%

Insiders by value of RNAC holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Timothy A. SpringerDirector8,976,980$52.9M28.0%1111th
2Murat Kalayoglu10% owner7,718,890$45.5M24.1%2716th
3Elizabeth Hoge10% owner2,656,631$15.6M8.30%6212th
4Timothy C. BarabeDirector56,966$336K0.18%9717th
5Carrie Smith CoxDirector15,629$92K<0.1%4398th
6Patrick ZennerDirector12,974$76K<0.1%6132nd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Cartesian Therapeutics; see each profile for the filing.